Intravenous (IV) Solutions: Market Research Report

Date: August 22, 2011
Pages: 274
Price:
US$ 4,800.00
Publisher: Global Industry Analysts, Inc
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: I68DAEB0490EN
Leaflet:

Download PDF Leaflet

Intravenous (IV) Solutions: Market Research Report
This report analyzes the worldwide markets for Intravenous (IV) Solutions in US$ Million.

The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World.

Annual estimates and forecasts are provided for the period 2009 through 2017.

Also, a six-year historic analysis is provided for these markets.

The report profiles 34 companies including many key and niche players such as B. Braun Melsungen AG, Baxter International, Inc., Baxter India Private Limited, Claris Lifesciences Ltd., Fresenius SE & Co. KGaA, Fresenius Kabi AG, Galenica Ltd., Grifols S.A., Hospira, Inc., Sichuan Kelun Pharmaceutical Co., Ltd., Liqvor Pharmaceuticals, Marck Biosciences Ltd., Otsuka Pharmaceutical Co.Ltd., Pfizer, Inc., Sino-Swed Pharmaceutical, Terumo Corporation, and Watson Pharmaceuticals, Inc.

Market data and analytics are derived from primary and secondary research.

Company profiles are mostly extracted from URL research and reported select online sources.
1.INTRODUCTION, METHODOLOGY & PRODUCT DEFINITION

Study Reliability and Reporting Limitations
Disclaimers
Data Interpretation & Reporting Level
Quantitative Techniques & Analytics
Product Definitions and Scope of Study

2.INDUSTRY OVERVIEW

IV Solutions: Steady Growth Prospects
Current and Future Analysis
Healthcare Industry: Impact of Recession
The Need for Low-Cost Solutions
Clinical Nutrition – Addressing Patients’ Nutritional Requirements
Global Parenteral Nutrition Market

Table 1. Leading Players in the Global Parenteral Nutrition Market (2010E): Percentage Share Breakdown of Value Sales for Baxter, Fresenius Kabi, B. Braun Melsungen, Hospira, and Others (includes corresponding Graph/Chart)

Peripheral Intravenous Feeding Vs Central Venous Feeding
Intravenous Iron Drugs Market – An Overview

3.AN INTRODUCTION TO INTRAVENOUS THERAPY

Intravenous Therapy
Volume Expanders – Colloids and Crystalloids
Blood and Blood-Based Products
Medications

4.INTRAVENOUS SOLUTIONS

Defining Intravenous Solutions
Tonicity and Osmolality
Production of IV Solutions
Types of IV Solutions
Colloid Solutions
Crystalloid Solutions
Properties of IV Solution Type Based on Concentration
Isotonic Crystalloids
Hypertonic Crystalloids
Hypotonic Crystalloids
Commonly Used Crystalloid Solutions
Saline Solution
Normal Saline
Half-Normal Saline
Quarter-Normal Saline
Hypertonic Saline
Dextrose
Saline with Additional Ingredients
Intravenous Sugar Solution
Dextrose Solutions or D5W
Other Types
Pre-mixed IV Solutions
Large and Small Volume Intravenous Solutions
Devices Used in IV Solutions Administration
Types of Intravenous Access Devices
Peripheral Cannula
Central IV Lines
ImplanTable Ports
Tunneled Lines
Peripherally Inserted Central Catheter (PICC)
IV Fluid Packaging
Possible Risks in Intravenous Therapy
Embolism
Electrolyte Imbalance
Extravasation/Infiltration
Phlebitis
Infection

5.INTRAVENOUS NUTRITIONAL THERAPY

An Introduction
Parenteral Nutrition
Routes of Application
Types of Parenteral Nutrition Solutions
Total Parenteral Nutrition (TPN)
Daily Requirements for Total Parenteral Nutrition in Adults
Partial Parenteral Nutrition (PPN)
Home Parenteral Nutrition
Classification of Parenteral Nutrition by Type of Nutrients
Amino Acids
Carbohydrates
Lipids
Minerals & Electrolytes
Micronutrients
Vitamins
Trace Elements
Large and Small Volume Parenteral (LVP) Solutions
Large Volume Parenteral Solutions
Small Volume Parenteral (SVP) Solutions
IV Fat Emulsions – Enabling Maintenance of Bodyweight

6.PRODUCT LAUNCHES

Bioniche Introduces Mefoxin® Premix IV Solution
Marck Biosciences Introduces Paracetamol IV in Plastic Pack
Grifols Introduces Flebogamma® 10% DIF in the US
Grifols Introduces Niuliva®
Galenica Launches Ferinject in Europe
B. Braun Unveils New Infusion Pumps in the US

7.RECENT INDUSTRY ACTIVITY

Pfizer Takes Over King Pharmaceuticals
Grifols to Set Up Form-Fill-Seal Production Lines for Parenteral Solutions
FMC and Vifor Pharma Team Up to Form Vifor Fresenius
Marck Biosciences Snaps Up Injectible Facility of Ravish Infusion
Lijun Forms JV with Tonghua Dongbao Pharmaceuticals
ADIH and Bram S.p.A. Ink Agreement for Wellpharma’s IV Production Facility
Hospira Signs Multi-product Agreements with MedAssets
Hospira Enters into Agreements with Novation
Prism Pharmaceuticals Obtains FDA approval for NEXTERONE®
Mission Health System Commences Production of RIVA-produced IV Solution
Mission Health Systems Selects Automation Solution from HIS
Applied Research Associates Bags Contract for Packaged Intravenous Fluids
Bivigam™ Dossier Submitted to US FDA by Biotest
Grifols Bags EMA License for Marketing Flebogamma® DIF 100mg/ml
Hospira Announces Migration to Non-DEHP Based IV Administration Units
Grifols and Health Robotics Ink Collaboration Agreement
Marck Biosciences Obtains Approval for Low Volume Parenteral Plant
Grifols Receives Approval for Sterile Albumin Filling Unit
Grifols Establishes New Production Unit
Fresenius Medical to Form JV with Galenica
B. Braun Inks Agreement with Health Robotics
Fresenius Medical Care Closes Agreement with Luitpold Pharmaceuticals
Grifols Receives Approval for Intravenous Immunoglobulin Flebogamma® DIF

8.FOCUS ON SELECT PLAYERS

B. Braun Melsungen AG (Germany)
Baxter International, Inc. (US)
Baxter India Private Limited (India)
Claris Lifesciences Ltd. (India)
Fresenius SE & Co. KGaA (Germany)
Fresenius Kabi AG (Germany)
Galenica Ltd. (Switzerland)
Grifols S.A. (Spain)
Hospira, Inc. (US)
Sichuan Kelun Pharmaceutical Co., Ltd.
Liqvor Pharmaceuticals (Armenia)
Marck Biosciences Ltd. (India)
Otsuka Pharmaceutical Co. Ltd. (Japan)
Pfizer, Inc. (US)
Sino-Swed Pharmaceutical (China)
Terumo Corporation (Japan)
Watson Pharmaceuticals, Inc. (US)

9.GLOBAL MARKET PERSPECTIVE

Table 2. World Recent Past, Current and Future Analysis for Intravenous Solutions by Geographic Region – US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for the Years 2009 through 2017 (includes corresponding Graph/Chart)
Table 3. World Historic Review for Intravenous Solutions by Geographic Region – US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for the Years 2003 through 2008 (includes corresponding Graph/Chart)
Table 4. World 15-Year Perspective for Intravenous Solutions by Geographic Region – Percentage Breakdown of Value Sales for US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets for the Years 2003, 2010 and 2017 (includes corresponding Graph/Chart)

10.THE UNITED STATES

A. MARKET ANALYSIS

Outlook
Market Overview

Table 5. US Population by Age Group and Gender (2010E) (includes corresponding Graph/Chart)


B. MARKET ANALYTICS

Table 6. US Recent Past, Current and Future Analysis for Intravenous Solutions Analyzed with Annual Sales Figures in US$ Million for the Years 2009 through 2017 (includes corresponding Graph/Chart)
Table 7. US Historic Review for Intravenous Solutions Analyzed with Annual Sales Figures in US$ Million for the Years 2003 through 2008 (includes corresponding Graph/Chart)

11.CANADA

Market Analysis

Table 8. Canadian Recent Past, Current and Future Analysis for Intravenous Solutions Analyzed with Annual Sales Figures in US$ Million for the Years 2009 through 2017 (includes corresponding Graph/Chart)
Table 9. Canadian Historic Review for Intravenous Solutions Analyzed with Annual Sales Figures in US$ Million for the Years 2003 through 2008 (includes corresponding Graph/Chart)

12.JAPAN

Market Analysis

Table 10. Japanese Recent Past, Current and Future Analysis for Intravenous Solutions Analyzed with Annual Sales Figures in US$ Million for the Years 2009 through 2017 (includes corresponding Graph/Chart)
Table 11. Japanese Historic Review for Intravenous Solutions Analyzed with Annual Sales Figures in US$ Million for the Years 2003 through 2008 (includes corresponding Graph/Chart)

13.EUROPE

Market Analysis

Table 12. European Recent Past, Current and Future Analysis for Intravenous Solutions by Geographic Region – France, Germany, Italy, UK, Spain, Russia, and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Million for the Years 2009 through 2017 (includes corresponding Graph/Chart)
Table 13. European Historic Review for Intravenous Solutions by Geographic Region – France, Germany, Italy, UK, Spain, Russia, and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Million for the Years 2003 through 2008 (includes corresponding Graph/Chart)
Table 14. European 15-Year Perspective for Intravenous Solutions by Geographic Region – Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia, and Rest of Europe Markets for the Years 2003, 2010 and 2017 (includes corresponding Graph/Chart)

14.ASIA-PACIFIC

A. MARKET ANALYSIS

Outlook
IV Solutions Market in China

Table 15. IV Solutions Products Packaging in China (2009): Percentage Share Breakdown of Volume Sales for Glass Bottles, and Plastic Bottles & Non-PVC Soft Bags


B. MARKET ANALYTICS

Table 16. Asia-Pacific Recent Past, Current and Future Analysis for Intravenous Solutions Analyzed with Annual Sales Figures in US$ Million for the Years 2009 through 2017 (includes corresponding Graph/Chart)
Table 17. Asia-Pacific Historic Review for Intravenous Solutions Analyzed with Annual Sales Figures in US$ Million for the Years 2003 through 2008 (includes corresponding Graph/Chart)

15.LATIN AMERICA

Market Analysis

Table 18. Latin American Recent Past, Current and Future Analysis for Intravenous Solutions Analyzed with Annual Sales Figures in US$ Million for the Years 2009 through 2017 (includes corresponding Graph/Chart)
Table 19. Latin American Historic Review for Intravenous Solutions Analyzed with Annual Sales Figures in US$ Million for the Years 2003 through 2008 (includes corresponding Graph/Chart)

16.REST OF WORLD

A. MARKET ANALYSIS

Outlook
Middle East
Uganda

B. MARKET ANALYTICS

Table 20. Rest of World Recent Past, Current and Future Analysis for Intravenous Solutions Analyzed with Annual Sales Figures in US$ Million for the Years 2009 through 2017 (includes corresponding Graph/Chart)
Table 21. Rest of World Historic Review for Intravenous Solutions Analyzed with Annual Sales Figures in US$ Million for the Years 2003 through 2008 (includes corresponding Graph/Chart)

COMPETITIVE LANDSCAPE

Total Companies Profiled: 34 (including Divisions/Subsidiaries - 46)
Region/CountryPlayers
The United States
Canada
Japan
Europe
France
Germany
The United Kingdom
Spain
Rest of Europe
Asia-Pacific (Excluding Japan)
Middle-East
Africa
Skip to top


Ask Your Question

Intravenous (IV) Solutions: Market Research Report
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: